Vault-13

PURE BIOSCIENCE INC PURE

COMMON STOCK · Common Stock · CUSIP 74621T209

1 institutional holders +0 vs Q1 2021
13,83013.8k shares reported held*
0.0% of all shares outstanding*
$6.0kreported value*
0 new 0 added 0 reduced 0 sold out net bought ≈ $0

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 87.2m as of 2021-06-15, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $0.43.

Trends to Q2 2021

Institutional holders

Managers reporting a position, each quarter

001Q1 20: 1Q2 20: 1Q3 20: 1Q4 20: 0Q1 21: 1Q2 21: 11Q1 20Q2 20Q3 20Q4 20Q1 21Q2 21
Numbers
QuarterHolders
Q1 20201
Q2 20201
Q3 20201
Q4 20200
Q1 20211
Q2 20211

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q2 20: 0 bought or addedQ2 20: 1 cut or sold outQ2 20Q3 20: 0 bought or addedQ3 20: 0 cut or sold outQ3 20Q2 21: 0 bought or addedQ2 21: 0 cut or sold outQ2 21
Numbers
QuarterBought or addedCut or sold out
Q2 202001
Q3 202000
Q2 202100

Insider purchases and sales in Q2 2021

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
101Q3 19: 0 buyingQ3 19: 0 sellingQ4 19: 0 buyingQ4 19: 0 sellingQ4 19Q1 20: 0 buyingQ1 20: 0 sellingQ2 20: 1 buyingQ2 20: 0 sellingQ2 20Q3 20: 0 buyingQ3 20: 0 sellingQ4 20: 1 buyingQ4 20: 0 sellingQ4 20Q1 21: 0 buyingQ1 21: 0 sellingQ2 21: 1 buyingQ2 21: 0 sellingQ2 21
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q3 20190—0——
Q4 20190—0——
Q1 20200—0——
Q2 20201$445.7k0——
Q3 20200—0——
Q4 20201$52.3k0——
Q1 20210—0——
Q2 20211$15.5k0——
DateInsiderTradeSharesPrice ValueTheir holding
2021-06-16 Lee Tom Y Chief Executive Officer, director Bought 35,998 $0.43 $15.5k36.0k shares +1%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q2 2021

#ManagerLocationShares Value% of their portfolioChangeShares change
1 KIRR MARBACH & CO LLC /IN/ 0.00% of their portfolio COLUMBUS, IN 13,83013.8k $6.0k $6.0k 0.00% Unchanged